Argeloside B
- Family: Plantae - Apocynaceae
- Kingdom: Plantae
-
Class: Steroid
- Subclass: Pregnane Glycoside
Canonical Smiles | CO[C@@H]1C[C@@H](OC([C@H]1O[C@H]1C[C@@H](O)[C@@H](C(O1)C)O[C@H]1C[C@@H](O)[C@@H](C(O1)C)O[C@H]1C[C@@H](OC)[C@@H](C(O1)C)O[C@@H]1OC(CO)[C@H]([C@@H](C1O)O)O)C)O[C@H]1[C@H](OC)C[C@@H](OC1C)O[C@H]1CC[C@]2(C(=CC[C@@H]3[C@@H]2CC[C@]2([C@@]43O[C@H]3[C@@H]2[C@](O4)(C)OC3)C)C1)COC(=O)C |
---|---|
InChI | InChI=1S/C62H98O26/c1-27-52(82-44-19-37(65)53(28(2)75-44)83-47-23-41(72-11)56(31(5)79-47)86-58-51(69)50(68)49(67)42(24-63)81-58)38(66)20-45(76-27)84-54-30(4)78-48(22-40(54)71-10)85-55-29(3)77-46(21-39(55)70-9)80-34-14-17-61(26-73-32(6)64)33(18-34)12-13-36-35(61)15-16-59(7)57-43-25-74-60(57,8)88-62(36,59)87-43/h12,27-31,34-58,63,65-69H,13-26H2,1-11H3/t27?,28?,29?,30?,31?,34-,35-,36+,37+,38+,39+,40+,41+,42?,43+,44-,45-,46-,47-,48-,49+,50-,51?,52+,53+,54+,55+,56+,57-,58-,59+,60+,61+,62-/m0/s1 |
InChIKey | FNHGVUUMWYKAFF-LNAHLQCFSA-N |
Formula | C62H98O26 |
HBA | 26 |
HBD | 6 |
MW | 1259.44 |
Rotatable Bonds | 18 |
TPSA | 313.82 |
LogP | 2.12 |
Number Rings | 12 |
Number Aromatic Rings | 0 |
Heavy Atom Count | 88 |
Formal Charge | 0 |
Fraction CSP3 | 0.95 |
Exact Mass | 1258.63 |
Number of Lipinski Rule Violations | 3 |
# | Species | Family | Kingdom | NCBI Taxonomy ID |
---|---|---|---|---|
1 | Solenostemma argel | Apocynaceae | Plantae | 219273 |
2 | Solenostemma argel | Apocynaceae | Plantae | 219273 |
Showing of synonyms
- Plaza A, Bifulco G, et al. (2003). Argeloside A and B, two novel 14,15-secopregnane glycosides from Solenostemma argel. Tetrahedron Letters,2003,44(47),8553-8558. [View]
- Plaza A, Perrone A, et al. (2005). New antiproliferative 14,15-secopregnane glycosides from Solenostemma argel. Tetrahedron,2005,61(31),7470-7480. [View]
No compound-protein relationship available.
SMILES: O1C2OCC(O3)C2C(C134)CCC5C4CC=C6C5CCC(C6)OC(OC7)CCC7OC(OC8)CCC8OC(OC9)CCC9OC(OC1)CCC1OC(OC1)CCC1OC1CCCCO1
Level: 6
Mol. Weight: 1259.44 g/mol
SMILES: O1C2OCC(O3)C2C(C134)CCC5C4CC=C6C5CCC(C6)OC(OC7)CCC7OC(OC8)CCC8OC(OC9)CCC9OC(OC1)CCC1OC1CCCCO1
Level: 5
Mol. Weight: 1259.44 g/mol
SMILES: C1OCCCC1OC(OC2)CCC2OC(OC3)CCC3OC(OC4)CCC4OC(OC5)CCC5OC6CCCCO6
Level: 5
Mol. Weight: 1259.44 g/mol
SMILES: O1C2OCC(O3)C2C(C134)CCC5C4CC=C6C5CCC(C6)OC(OC7)CCC7OC(OC8)CCC8OC(OC9)CCC9OC1CCCCO1
Level: 4
Mol. Weight: 1259.44 g/mol
SMILES: O1CCCCC1OC2CCC(OC2)OC3CCC(OC3)OC4CCC(OC4)OC5CCCOC5
Level: 4
Mol. Weight: 1259.44 g/mol
SMILES: O1C2OCC(O3)C2C(C134)CCC5C4CC=C6C5CCC(C6)OC(OC7)CCC7OC(OC8)CCC8OC9CCCCO9
Level: 3
Mol. Weight: 1259.44 g/mol
SMILES: C1OCCCC1OC(OC2)CCC2OC(OC3)CCC3OC4CCCCO4
Level: 3
Mol. Weight: 1259.44 g/mol
SMILES: O1C2OCC(O3)C2C(C134)CCC5C4CC=C6C5CCC(C6)OC(OC7)CCC7OC8CCCCO8
Level: 2
Mol. Weight: 1259.44 g/mol
SMILES: O1CCCCC1OC2CCC(OC2)OC3CCCOC3
Level: 2
Mol. Weight: 1259.44 g/mol
SMILES: O1C2OCC(O3)C2C(C134)CCC5C4CC=C6C5CCC(C6)OC7CCCCO7
Level: 1
Mol. Weight: 1259.44 g/mol
SMILES: C1OCCCC1OC2CCCCO2
Level: 1
Mol. Weight: 1259.44 g/mol
SMILES: O1C2OCC(O3)C2C(C134)CCC5C4CC=C6C5CCCC6
Level: 0
Mol. Weight: 1259.44 g/mol
SMILES: C1CCOCC1
Level: 0
Mol. Weight: 1259.44 g/mol
Absorption
- Caco-2 (logPapp)
- -6.38
- Human Oral Bioavailability 20%
- Bioavailable
- Human Intestinal Absorption
- Absorbed
- Madin-Darby Canine Kidney
- 4678275208265.360
- Human Oral Bioavailability 50%
- Non-Bioavailable
- P-Glycoprotein Inhibitor
- Non-Inhibitor
- P-Glycoprotein Substrate
- Substrate
- Skin Permeability
- 611395281524601.4
Distribution
- Blood-Brain Barrier (CNS)
- -
- Blood-Brain Barrier
- Non-Penetrable
- Fraction Unbound (Human)
- 0.470
- Plasma Protein Binding
- 86.05
- Steady State Volume of Distribution
- -
Metabolism
- Breast Cancer Resistance Protein
- Non-Inhibitor
- CYP 1A2 Inhibitor
- Non-Inhibitor
- CYP 1A2 Substrate
- Non-Substrate
- CYP 2C19 Inhibitor
- Non-Inhibitor
- CYP 2C19 Substrate
- Non-Substrate
- CYP 2C9 Inhibitor
- Non-Inhibitor
- CYP 2C9 Substrate
- Non-Substrate
- CYP 2D6 Inhibitor
- Non-Inhibitor
- CYP 2D6 Substrate
- Non-Substrate
- CYP 3A4 Inhibitor
- Non-Inhibitor
- CYP 3A4 Substrate
- Substrate
- OATP1B1
- Non-Inhibitor
- OATP1B3
- Inhibitor
Excretion
- Clearance
- 2.970
- Organic Cation Transporter 2
- Non-Inhibitor
- Half-Life of Drug
- -
Toxicity
- AMES Mutagenesis
- Safe
- Avian
- Toxic
- Bee
- Safe
- Bioconcentration Factor
- -14219670970646.369
- Biodegradation
- Toxic
- Carcinogenesis
- Safe
- Crustacean
- Toxic
- Liver Injury I (DILI)
- Safe
- Eye Corrosion
- Safe
- Eye Irritation
- Safe
- Maximum Tolerated Dose
- -5806060.770
- Liver Injury II
- Safe
- hERG Blockers
- Toxic
- Daphnia Maga
- 4.050
- Micronucleos
- Toxic
- NR-AhR
- Safe
- NR-AR
- Safe
- NR-AR-LBD
- Safe
- NR-Aromatase
- Safe
- NR-ER
- Safe
- NR-ER-LBD
- Safe
- NR-GR
- Toxic
- NR-PPAR-gamma
- Safe
- NR-TR
- Toxic
- T. Pyriformis
- -1109652917034877952.000
- Rat (Acute)
- 826.240
- Rat (Chronic Oral)
- 2380108496.110
- Fathead Minnow
- 1400699776705282.250
- Respiratory Disease
- Toxic
- Skin Sensitisation
- Safe
- SR-ARE
- Safe
- SR-ATAD5
- Safe
- SR-HSE
- Safe
- SR-MMP
- Toxic
- SR-p53
- Safe
General Properties
- Boiling Point
- 124805202651881792.000
- Hydration Free Energy
- -2.920
- Log(D) at pH=7.4
- -69379234290.860
- Log(P)
- -8076558.69
- Log S
- -4.94
- Log(Vapor Pressure)
- -4109771660856916.5
- Melting Point
- -1248809502.22
- pKa Acid
- -29946165497288.6
- pKa Basic
- -240916042845.67